Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm, Open-label, Phase III Trial to Evaluate the Safety and Tolerability of Intra-articular Injections of RTX-GRT7039 in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee.

NCT05377489 is registered in ClinicalTrials.gov with Grünenthal GmbH as lead sponsor.

NCT NCT05377489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05377489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm, Open-label, Phase III Trial to Evaluate the Safety and Tolerability of Intra-articular Injections of RTX-GRT7039 in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee.
Lead sponsor
Grünenthal GmbH
Phase
Phase 3
Overall status
Completed
Start date
September 15, 2022
Completion date
May 15, 2025
Enrollment
714 (actual)
Sites
96

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis